Hubert Gorny
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hubert Gorny has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Beata Monfort
Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Gif-sur-Yvette, France
1 shared publication - Benoit D'AUtreaux
Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Gif-sur-Yvette, France
1 shared publication Ema Turki
Université Paris Cité, CNRS, Unit of Functional and Adaptive Biology (BFA), UMR 8251, Paris, France
1 shared publicationEstelle Jullian
Université Paris Cité, CNRS, Unit of Functional and Adaptive Biology (BFA), UMR 8251, Paris, France
1 shared publication- Isabelle Krimm
Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Institut Convergence Plascan
1 shared publication - Jordane Preto
Université Claude Bernard Lyon 1
1 shared publication
Latest Publications
- 8 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Conception de petites molécules ligands pour l’étude de la protéine VDAC1
Le canal anionique tensiodépendant VDAC1 (de l’anglais « voltage-dependent anion channel 1 ») est la protéine majoritaire de la membrane mitochondriale externe. Il permet le passage de tous les composés de masse inférieure à 5 kDa. Cette protéine est par conséquent le point de départ de nombreux processus métaboliques au sein de la mitochondrie. Son oligomérisation et ses interactions avec différents partenaires protéiques dont l’hexokinase en font aussi un régulateur essentiel de l’apoptose médiée par la mitochondrie. Des modifications de son activité et de son expression sont retrouvées dans de nombreuses pathologies (cancers, maladies neurodégénératives, maladies cardiaques, lupus, diabète de type 2 …). VDAC1 représente donc une cible avec un fort potentiel thérapeutique. Malgré cela, le canal reste largement inexploité à ce jour. Cela est dû, entre autres, au caractère inciblable (de l’anglais « undruggable ») de la structure du canal.Pour répondre à cette problématique, nous projetons de concevoir de nouveaux ligands avec une forte affinité et une forte spécificité pour VDAC1. Un criblage virtuel a été réalisé grâce à une approche dite « structure-based » utilisant la base de données ZINC15 comme chimiothèque. Les 54 molécules présentant les meilleurs scores ont été testées par NanoDSF et thermophorèse microéchelle sur VDAC1 humain recombinant. À partir des ligands de VDAC1 identifiés, deux séries chimiques ont été mises en évidence puis confirmées à l’aide d’études de déplacements chimiques par RMN. Des analogues issus de ces 2 séries ont été synthétisés afin de réaliser des études préliminaires de relation structure-activité.
- 8 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Conception de petites molécules ligands pour l’étude de la protéine VDAC1
Le canal anionique tensiodépendant VDAC1 (de l’anglais « voltage-dependent anion channel 1 ») est la protéine majoritaire de la membrane mitochondriale externe. Il permet le passage de tous les composés de masse inférieure à 5 kDa. Cette protéine est par conséquent le point de départ de nombreux processus métaboliques au sein de la mitochondrie. Son oligomérisation et ses interactions avec différents partenaires protéiques dont l’hexokinase en font aussi un régulateur essentiel de l’apoptose médiée par la mitochondrie. Des modifications de son activité et de son expression sont retrouvées dans de nombreuses pathologies (cancers, maladies neurodégénératives, maladies cardiaques, lupus, diabète de type 2 …). VDAC1 représente donc une cible avec un fort potentiel thérapeutique. Malgré cela, le canal reste largement inexploité à ce jour. Cela est dû, entre autres, au caractère inciblable (de l’anglais « undruggable ») de la structure du canal.Pour répondre à cette problématique, nous projetons de concevoir de nouveaux ligands avec une forte affinité et une forte spécificité pour VDAC1. Un criblage virtuel a été réalisé grâce à une approche dite « structure-based » utilisant la base de données ZINC15 comme chimiothèque. Les 54 molécules présentant les meilleurs scores ont été testées par NanoDSF et thermophorèse microéchelle sur VDAC1 humain recombinant. À partir des ligands de VDAC1 identifiés, deux séries chimiques ont été mises en évidence puis confirmées à l’aide d’études de déplacements chimiques par RMN. Des analogues issus de ces 2 séries ont été synthétisés afin de réaliser des études préliminaires de relation structure-activité.
- Open Access
- 10 December 2025
- Published by Springer Nature in Nature
- Vol. 649 (8097) , 721-728
Cross-regulation of [2Fe–2S] cluster synthesis by ferredoxin-2 and frataxin
Iron–sulfur (Fe–S) clusters are essential metallocofactors that perform a multitude of biological functions1,2,3,4,5,6,7. Their synthesis is tightly regulated and defects in this process lead to severe diseases8,9,10, such as Friedreich’s ataxia, which is caused by defective expression of frataxin (FXN)11. However, the underlying mechanisms that regulate this process remain unclear. Here we show that efficient Fe–S cluster assembly requires a fine-tuned balance in the ratio of FXN and ferredoxin-2 (FDX2). Fe–S clusters are assembled on the scaffold protein ISCU2; sulfur is provided as a persulfide by NFS1, and the persulfide is cleaved into sulfide by FDX2 (refs. 12,13). FXN stimulates the whole process by accelerating the transfer of persulfide to ISCU2 (refs. 12,14,15). Using an in-vitro-reconstituted human system, we show that any deviation from a close-to-equal amount of FXN and FDX2 downregulates Fe–S cluster synthesis. Structure–function investigation reveals that this is due to competition between FXN and FDX2 and their similar affinities for the same binding site on the NFS1–ISCU2 complex, with higher levels of FXN impairing the persulfide reductase activity of FDX2 and higher levels of FDX2 slowing the FXN-accelerated transfer of persulfide to ISCU2. We also find that FDX2 directly hinders persulfide generation and transfer to ISCU2 by interacting with the persulfide-carrying mobile loop of NFS1. We further show that knocking down the expression of FDX2 increases fly lifespan in a Drosophila model of Friedreich’s ataxia. Together, this work highlights a direct regulation of Fe–S cluster biosynthesis through antagonistic binding of FXN and FDX2, and suggests that decreasing FDX2 in the context of FXN deficiency in Friedreich’s ataxia might constitute a novel therapeutic axis.
- 10 December 2025
- Published by Springer Nature in Nature
- Vol. 649 (8097) , 721-728
Open AccessCross-regulation of [2Fe–2S] cluster synthesis by ferredoxin-2 and frataxin
Iron–sulfur (Fe–S) clusters are essential metallocofactors that perform a multitude of biological functions1,2,3,4,5,6,7. Their synthesis is tightly regulated and defects in this process lead to severe diseases8,9,10, such as Friedreich’s ataxia, which is caused by defective expression of frataxin (FXN)11. However, the underlying mechanisms that regulate this process remain unclear. Here we show that efficient Fe–S cluster assembly requires a fine-tuned balance in the ratio of FXN and ferredoxin-2 (FDX2). Fe–S clusters are assembled on the scaffold protein ISCU2; sulfur is provided as a persulfide by NFS1, and the persulfide is cleaved into sulfide by FDX2 (refs. 12,13). FXN stimulates the whole process by accelerating the transfer of persulfide to ISCU2 (refs. 12,14,15). Using an in-vitro-reconstituted human system, we show that any deviation from a close-to-equal amount of FXN and FDX2 downregulates Fe–S cluster synthesis. Structure–function investigation reveals that this is due to competition between FXN and FDX2 and their similar affinities for the same binding site on the NFS1–ISCU2 complex, with higher levels of FXN impairing the persulfide reductase activity of FDX2 and higher levels of FDX2 slowing the FXN-accelerated transfer of persulfide to ISCU2. We also find that FDX2 directly hinders persulfide generation and transfer to ISCU2 by interacting with the persulfide-carrying mobile loop of NFS1. We further show that knocking down the expression of FDX2 increases fly lifespan in a Drosophila model of Friedreich’s ataxia. Together, this work highlights a direct regulation of Fe–S cluster biosynthesis through antagonistic binding of FXN and FDX2, and suggests that decreasing FDX2 in the context of FXN deficiency in Friedreich’s ataxia might constitute a novel therapeutic axis.
- Open Access
- 21 January 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (3) , 1175
A Deep Dive into VDAC1 Conformational Diversity Using All-Atom Simulations Provides New Insights into the Structural Origin of the Closed States
The voltage-dependent anion channel 1 (VDAC1) is a crucial mitochondrial transporter that controls the flow of ions and respiratory metabolites entering or exiting mitochondria. As a voltage-gated channel, VDAC1 can switch between a high-conducting “open” state and a low-conducting “closed” state emerging at high transmembrane (TM) potentials. Although cell homeostasis depends on channel gating to regulate the transport of ions and metabolites, structural hallmarks characterizing the closed states remain unknown. Here, we performed microsecond accelerated molecular dynamics to highlight a vast region of VDAC1 conformational landscape accessible at typical voltages known to promote closure. Conformers exhibiting durable subconducting properties inherent to closed states were identified. In all cases, the low conductance was due to the particular positioning of an unfolded part of the N-terminus, which obstructed the channel pore. While the N-terminal tail was found to be sensitive to voltage orientation, our models suggest that stable low-conducting states of VDAC1 predominantly take place from disordered events and do not result from the displacement of a voltage sensor or a significant change in the pore. In addition, our results were consistent with conductance jumps observed experimentally and corroborated a recent study describing entropy as a key factor for VDAC gating.
- 21 January 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (3) , 1175
Open AccessA Deep Dive into VDAC1 Conformational Diversity Using All-Atom Simulations Provides New Insights into the Structural Origin of the Closed States
The voltage-dependent anion channel 1 (VDAC1) is a crucial mitochondrial transporter that controls the flow of ions and respiratory metabolites entering or exiting mitochondria. As a voltage-gated channel, VDAC1 can switch between a high-conducting “open” state and a low-conducting “closed” state emerging at high transmembrane (TM) potentials. Although cell homeostasis depends on channel gating to regulate the transport of ions and metabolites, structural hallmarks characterizing the closed states remain unknown. Here, we performed microsecond accelerated molecular dynamics to highlight a vast region of VDAC1 conformational landscape accessible at typical voltages known to promote closure. Conformers exhibiting durable subconducting properties inherent to closed states were identified. In all cases, the low conductance was due to the particular positioning of an unfolded part of the N-terminus, which obstructed the channel pore. While the N-terminal tail was found to be sensitive to voltage orientation, our models suggest that stable low-conducting states of VDAC1 predominantly take place from disordered events and do not result from the displacement of a voltage sensor or a significant change in the pore. In addition, our results were consistent with conductance jumps observed experimentally and corroborated a recent study describing entropy as a key factor for VDAC gating.